Pyxis Oncology, Inc. (PYXS) Ownership

$1.76

north_east
$0.06 (3.53%)
Day's range
$1.68
Day's range
$1.78

Pyxis Oncology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PFIZER INC 02/14/2025 7.03 M $10.97 M   100.00% 11.58%
LAURION CAPITAL MANAGEMENT LP 02/14/2025 3.63 M $5.66 M   0.00% 5.97%
BLACKROCK FUNDING, INC. /DE 02/07/2025 3.34 M $5.22 M   12.82% 5.51%
MILLENNIUM MANAGEMENT LLC 02/14/2025 2.98 M $4.65 M   56.32% 4.91%
VANGUARD GROUP INC 02/11/2025 2.44 M $3.81 M   0.34% 4.02%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.08 M $1.69 M   -0.21% 1.78%
PALO ALTO INVESTORS LP 02/14/2025 1.04 M $1.62 M   510.25% 1.71%
ABRDN PLC 01/24/2025 913,045 $1.42 M   0.00% 1.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 832,200 $1.30 M   3,396.64% 1.37%
IKARIAN CAPITAL, LLC 02/14/2025 613,253 $956,675   -35.95% 1.01%
UBS GROUP AG 02/14/2025 446,699 $696,851   1,489.56% 0.74%
683 CAPITAL MANAGEMENT, LLC 02/14/2025 415,000 $647,400   0.08% 0.68%
HHLR ADVISORS, LTD. 02/14/2025 382,606 $596,865   0.00% 0.63%
RIDGEBACK CAPITAL INVESTMENTS L.P. 02/14/2025 359,231 $560,400   100.00% 0.59%
DECHENG CAPITAL LLC 02/14/2025 326,810 $509,824   0.00% 0.54%
AMERICAN CENTURY COMPANIES INC 02/11/2025 299,937 $467,902   88.12% 0.49%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 293,354 $457,632   82.96% 0.48%
BANK OF NEW YORK MELLON CORP 02/04/2025 272,769 $425,520   0.00% 0.45%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 269,995 $421,192   1.77% 0.44%
PERCEPTIVE ADVISORS LLC 02/14/2025 188,462 $294,001   -62.93% 0.31%
GOLDMAN SACHS GROUP INC 02/11/2025 184,702 $288,135   32.75% 0.30%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 181,042 $282,426   -36.17% 0.30%
MARSHALL WACE, LLP 02/13/2025 157,953 $246,407   35.75% 0.26%
UBS OCONNOR LLC 02/14/2025 146,400 $228,384   100.00% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 129,761 $202,427   0.00% 0.21%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 127,304 $198,594   -14.57% 0.21%
ARISTIDES CAPITAL LLC 02/13/2025 124,000 $193,440   100.00% 0.20%
SCHULHOFF & CO INC 02/05/2025 122,000 $190,320   0.00% 0.20%
MAIA WEALTH LLC 02/05/2025 118,900 $951   100.00% 0.20%
NEWEDGE WEALTH, LLC 02/05/2025 116,009 $180,974   0.00% 0.19%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 111,051 $173,239   35.52% 0.18%
PIER 88 INVESTMENT PARTNERS LLC 02/12/2025 98,590 $153,800   -18.93% 0.16%
STATE OF WISCONSIN INVESTMENT BOARD 02/14/2025 85,600 $133,536   100.00% 0.14%
FMR LLC 02/13/2025 84,888 $132,425   2,037.16% 0.14%
LMR PARTNERS LLP 02/14/2025 77,300 $120,588   -3.38% 0.13%
BARCLAYS PLC 02/13/2025 77,013 $121,000   20.17% 0.13%
YU FAN 02/14/2025 69,303 $108,113   0.00% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 67,975 $106,041   -20.79% 0.11%
RHUMBLINE ADVISERS 01/30/2025 67,851 $105,842   5.31% 0.11%
JANE STREET GROUP, LLC 02/14/2025 67,686 $105,590   36.58% 0.11%
CABLE CAR CAPITAL LLC 02/14/2025 61,606 $96,105   0.00% 0.10%
SEI INVESTMENTS CO 02/11/2025 61,140 $95,378   100.00% 0.10%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 50,080 $78,125   100.00% 0.08%
UNIVERSITY OF CHICAGO 02/05/2025 48,731 $76,020   0.00% 0.08%
CITIGROUP INC 02/12/2025 42,088 $65,657   18.31% 0.07%
DEUTSCHE BANK AG\ 02/14/2025 30,300 $47,268   -87.29% 0.05%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/14/2025 30,287 $47,248   100.00% 0.05%
WELLS FARGO & COMPANY/MN 02/13/2025 28,949 $45,161   19.50% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 28,011 $43,697   4.54% 0.05%
ROYAL BANK OF CANADA 02/14/2025 27,653 $44,000   -21.72% 0.05%

Pyxis Oncology, Inc. institutional Ownership - FAQ's

During the previous two years, 113 institutional investors and hedge funds held shares of Pyxis Oncology, Inc.. The most heavily invested institutionals were:

PFIZER INC: 7.03 M

Laurion Capital Management LP: 3.63 M

BlackRock Funding, Inc. /DE: 3.34 M

MILLENNIUM MANAGEMENT LLC: 2.98 M

VANGUARD GROUP INC: 2.44 M

GEODE CAPITAL MANAGEMENT, LLC: 1.08 M

51.94% of Pyxis Oncology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 34.39 M shares in the last 24 months. This purchase volume represents approximately $60.52 M in transactions.